id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1082-0018,FDA,FDA-2020-N-1082,"Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assay Devices, Renamed to Hepatitis C Virus Antibody Tests",Rule,Final Rule,2021-11-22T05:00:00Z,2021,11,2021-11-22T05:00:00Z,,2021-11-22T15:48:14Z,2021-25374,0,0,0900006484e71277
FDA-2020-N-1082-0002,FDA,FDA-2020-N-1082,"Reference 5 - Aisyah et al Journal Viral Hep 2018 re Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests",Supporting & Related Material,Background Material,2020-04-02T04:00:00Z,2020,4,,,2020-04-02T13:16:28Z,,0,0,090000648447e9b0
FDA-2020-N-1082-0003,FDA,FDA-2020-N-1082,"Reference 6 - Moorman et al Heptaology 2015 re Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests",Supporting & Related Material,Background Material,2020-04-02T04:00:00Z,2020,4,,,2020-04-02T13:17:48Z,,0,0,090000648447e9b1
FDA-2020-N-1082-0004,FDA,FDA-2020-N-1082,"Reference 7 - Ioannou et al Journal of Hepatology 2018 re Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests",Supporting & Related Material,Background Material,2020-04-02T04:00:00Z,2020,4,,,2020-04-02T13:19:37Z,,0,0,090000648447e9b2
FDA-2020-N-1082-0001,FDA,FDA-2020-N-1082,"Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests",Proposed Rule,Amendment,2020-04-02T04:00:00Z,2020,4,2020-04-02T04:00:00Z,2020-06-02T03:59:59Z,2020-06-03T01:03:28Z,2020-06821,0,0,090000648448123d